Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2007 4
2008 2
2010 1
2012 4
2014 4
2015 3
2016 2
2017 1
2018 7
2019 8
2020 2
2021 4
2022 5
2023 5
2024 7
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Assessing differential application of thromboprophylaxis regimes related to risk of pulmonary embolism and mortality in COVID-19 patients through instrumental variable analysis.
Nab L, Visser C, van Bussel BCT, Beishuizen A, Bemelmans RHH, Ten Cate H, Croles FN, van Guldener C, de Jager CPC, Huisman MV, Nijziel MR, Kamphuisen PW, Klok FA, Koster SCE, Kuşadasi N, Meijer K, den Uil CA, Schutgens REG, Stam F, Vlaar APJ, Vlot EA, Linschoten MPM, Asselbergs FW, Kruip MJHA, le Cessie S, Cannegieter SC; Dutch Covid and Thrombosis Coalition & the CAPACITY-COVID collaborative consortium. Nab L, et al. Sci Rep. 2025 Mar 25;15(1):10321. doi: 10.1038/s41598-024-77858-w. Sci Rep. 2025. PMID: 40133355 Free PMC article.
Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs.
Linthorst NA, Jongejan YK, Dirven RJ, Laan SNJ, Bierings R, Casari C, Cordfunke RA, Dahlman JE, Dolezal N, Drijfhout JW, Leebeek FWG, Ruhaak LR, Schrader Echeverri E, Voorberg J, van Vlijmen BJM, Denis CV, Eikenboom JCJ. Linthorst NA, et al. Among authors: bierings r. Blood Adv. 2025 Jan 28;9(2):310-320. doi: 10.1182/bloodadvances.2024014601. Blood Adv. 2025. PMID: 39820471 Free PMC article.
Functional characterization of a nanobody-based glycoprotein VI-specific platelet agonist.
Zivkovic M, Pols-van Veen E, van der Vegte V, Sebastian SAE, de Moor AS, Korporaal SJA, Schutgens REG, Urbanus RT; Thrombocytopathy in the Netherlands (TiN) study group; SYMPHONY consortium. Zivkovic M, et al. Res Pract Thromb Haemost. 2024 Oct 3;8(7):102582. doi: 10.1016/j.rpth.2024.102582. eCollection 2024 Oct. Res Pract Thromb Haemost. 2024. PMID: 39512585 Free PMC article.
The severe von Willebrand disease variant p.M771V leads to impaired anterograde trafficking of von Willebrand factor in patient-derived and base-edited endothelial colony-forming cells.
Bär I, Barraclough A, Bürgisser PE, van Kwawegen C, Fijnvandraat K, Eikenboom JCJ, Leebeek FWG, Voorberg J, Bierings R. Bär I, et al. Among authors: bierings r. J Thromb Haemost. 2025 Feb;23(2):466-479. doi: 10.1016/j.jtha.2024.10.023. Epub 2024 Nov 6. J Thromb Haemost. 2025. PMID: 39510415 Free article.
Variant mapping using mass spectrometry-based proteotyping as a diagnostic tool in von Willebrand disease.
Kreft IC, van Duijl TT, van Kwawegen C, Atiq F, Phan W, Schuller MBP, Boon-Spijker M, van der Zwaan C, Meijer AB, Hoogendijk AJ, Bierings R, Eikenboom JCJ, Leebeek FWG, van den Biggelaar M; Willebrand in the Netherlands (WiN) study group. Kreft IC, et al. Among authors: bierings r. J Thromb Haemost. 2024 Jul;22(7):1894-1908. doi: 10.1016/j.jtha.2024.04.011. Epub 2024 Apr 27. J Thromb Haemost. 2024. PMID: 38679335 Free article.
64 results